• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Distribution of salicylate between neonatal and maternal serum at diffusion equilibrium.

作者信息

Levy G, Procknal J A, Garrettson L K

出版信息

Clin Pharmacol Ther. 1975 Aug;18(2):210-4. doi: 10.1002/cpt1975182210.

DOI:10.1002/cpt1975182210
PMID:1157445
Abstract

The post-distributive neonatal:maternal plasma salicylate concentration ratio following salicylate administration to the mother before delivery is appreciably higher than unity. The protein binding of salicylate and the albumin concentration in one such plasma pair were considerably higher in the neonatal than in the maternal plasma. Equilibrium dialysis of neonatal plasma or serum from 6 newborn infants against that of their mothers produced a neonatal: maternal salicylate concentration ratio above unity in all cases even if the albumin concentration in the neonatal serum did not exceed that in the maternal serum. However, there was a strong correlation between the neonatal:maternal concentration ratios of salicylate and albumin. These observations demonstrate that conclusions concerning the distribution of a drug across the placenta in relation to its plasma protein binding characteristics must be based on the results of binding studies with plasma or serum from neonates and their mothers, and not from other adult subjects.

摘要

相似文献

1
Distribution of salicylate between neonatal and maternal serum at diffusion equilibrium.
Clin Pharmacol Ther. 1975 Aug;18(2):210-4. doi: 10.1002/cpt1975182210.
2
Fetal acquisition and neonatal elimination of a large amount of salicylate. Study of a neonate whose mother regularly took therapeutic doses of aspirin during pregnancy.
Clin Pharmacol Ther. 1975 Jan;17(1):98-103. doi: 10.1002/cpt197517198.
3
Salicylate saturation index in neonatal jaundice.新生儿黄疸中的水杨酸盐饱和指数。
Biol Neonate. 1975;26(1-2):67-75. doi: 10.1159/000240718.
4
Salicylate exposure in the perinate.围产期水杨酸盐暴露
JAMA. 1969 Jul 28;209(4):556-8.
5
The influence of maternal protein deficiency on the placental transfer of salicylate in rats.母体蛋白质缺乏对大鼠水杨酸盐胎盘转运的影响。
Br J Pharmacol. 1983 Jan;78(1):233-8. doi: 10.1111/j.1476-5381.1983.tb09384.x.
6
Serum protein binding of salicylate during pregnancy and the puerperium.
Dev Pharmacol Ther. 1981;2(3):172-9.
7
Bilirubin-albumin binding in neonatal salicylate intoxication.
Dev Pharmacol Ther. 1982;4(1-2):47-60. doi: 10.1159/000457390.
8
Salsalate and salicylate binding to and their displacement of thyroxine from thyroxine-binding globulin, transthyrin, and albumin.双水杨酯和水杨酸盐与甲状腺素结合球蛋白、转甲状腺素蛋白及白蛋白的结合及其对甲状腺素的置换作用。
Thyroid. 1999 Apr;9(4):359-64. doi: 10.1089/thy.1999.9.359.
9
Decreased protein binding of salicylates in Kawasaki disease.川崎病中水杨酸盐的蛋白结合率降低。
J Pediatr. 1991 Mar;118(3):456-9. doi: 10.1016/s0022-3476(05)82168-7.
10
Drug binding to plasma proteins during human pregnancy and in the perinatal period. Studies on cloxacillin and alprenolol.人类孕期及围产期药物与血浆蛋白的结合。关于氯唑西林和阿普洛尔的研究。
Dev Pharmacol Ther. 1983;6(2):110-24. doi: 10.1159/000457284.

引用本文的文献

1
Physiologic Changes During Pregnancy and Impact on Small-Molecule Drugs, Biologic (Monoclonal Antibody) Disposition, and Response.妊娠期间的生理变化及其对小分子药物、生物(单克隆抗体)处置和反应的影响。
J Clin Pharmacol. 2023 Jun;63 Suppl 1(Suppl 1):S34-S50. doi: 10.1002/jcph.2227.
2
Long-term outcomes following antenatal exposure to low-dose aspirin: study protocol for the 4-year follow-up of the APRIL randomised controlled trial.产前低剂量阿司匹林暴露的长期结局:APRIL 随机对照试验 4 年随访研究方案。
BMJ Open. 2022 Aug 8;12(8):e060632. doi: 10.1136/bmjopen-2021-060632.
3
A 19-year-old at 37 weeks gestation with an acute acetylsalicylic acid overdose.
一名19岁孕妇,妊娠37周,急性乙酰水杨酸过量。
NDT Plus. 2011 Dec;4(6):394-6. doi: 10.1093/ndtplus/sfr104. Epub 2011 Sep 16.
4
Pharmacokinetic changes during pregnancy and their clinical relevance.孕期的药代动力学变化及其临床意义。
Clin Pharmacokinet. 1997 Nov;33(5):328-43. doi: 10.2165/00003088-199733050-00002.
5
A clinical trial of a slow-release formulation of acetylsalicylic acid in patients at risk for preeclampsia.一项针对先兆子痫风险患者的乙酰水杨酸缓释制剂的临床试验。
Br J Clin Pharmacol. 1993 Jun;35(6):664-7. doi: 10.1111/j.1365-2125.1993.tb04200.x.
6
Clinical pharmacokinetics in the treatment of rheumatoid arthritis in pregnancy.孕期类风湿关节炎治疗中的临床药代动力学
Clin Pharmacokinet. 1993 Dec;25(6):444-9. doi: 10.2165/00003088-199325060-00004.
7
Pharmacokinetic optimisation of the treatment of embolic disorders.栓塞性疾病治疗的药代动力学优化
Clin Pharmacokinet. 1995 Jan;28(1):67-92. doi: 10.2165/00003088-199528010-00006.
8
Monitoring plasma concentrations of salicylate.监测水杨酸盐的血浆浓度。
Clin Pharmacokinet. 1980 Sep-Oct;5(5):424-40. doi: 10.2165/00003088-198005050-00002.
9
Placental transfer of etozolin and ozolinone during the first half of gestation in man.
Eur J Clin Pharmacol. 1982;23(3):253-60. doi: 10.1007/BF00547564.
10
Drug distribution in whole blood of mothers and their newborn infants: studies of cloxacillin and flucloxacillin.母亲及其新生儿全血中的药物分布:氯唑西林和氟氯西林的研究。
Eur J Clin Pharmacol. 1982;22(4):351-8. doi: 10.1007/BF00548405.